Samantha Sanches de Carvalho
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Samantha Sanches de Carvalho has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Glaucia Luciano da Veiga
Clinical Analysis Laboratory, Centro Universitário FMABC, Santo André, Brazil
7 shared publications - Thaís Moura Gascón
Clinical Analysis Laboratory, Centro Universitário FMABC, Santo André, Brazil
6 shared publications - Fernando Luiz Affonso Fonseca
Clinical Analysis Laboratory, Centro Universitário FMABC, Santo André, Brazil
5 shared publications - Beatriz da Costa Aguiar Alves
Laboratório de Análises Clínicas, Centro Universitário FMABC, Santo André 09060-870, Brazil
3 shared publications Fernando Luiz Affonso Fonseca
Clinical Analysis Laboratory, FMABC University Center, Santo André, São Paulo 09060‑870, Brazil
3 shared publicationsBeatriz da Costa Aguiar Alves
Clinical Analysis Laboratory, Centro Universitário Saúde ABC/ Faculdade de Medicina Do ABC, Santo André, Brasil
2 shared publications
Latest Publications
- Open Access
- 16 June 2026
- Published by MDPI AG in Journal of Clinical & Translational Ophthalmology
- Vol. 4 (2) , 16
Clinical Profile of Conjunctival and Eyelid Lesions in Patients Referred to the Ophthalmology Service of the Brazilian Public Health System (SUS)
Introduction: Conjunctival and eyelid lesions encompass a broad spectrum of conditions, ranging from benign entities to malignant neoplasms, and may significantly impact ocular health and quality of life. Their occurrence is influenced by environmental exposure, demographic characteristics, and access to healthcare services. In public health settings, delayed diagnosis and limited access to specialized care may contribute to disease progression. Objective: To characterize the clinical and epidemiological profile of conjunctival and eyelid lesions in patients treated at a referral ophthalmology service within the Brazilian Unified Health System (SUS). Methods: This retrospective observational study reviewed medical records of patients diagnosed with conjunctival and/or eyelid lesions during ophthalmologic screening campaigns. Clinical and demographic variables were analyzed using descriptive statistics to assess prevalence and distribution patterns. Results: A total of 66 patients were included. Conjunctival involvement predominated (78.8%), with the nasal region being the most frequently affected location (62.1%). Pterygium was the most prevalent diagnosis (31.8%), followed by racial melanosis (15.2%) and melanocytic nevus (12.1%). No statistically significant differences were observed according to sex or lesion laterality. However, a significant association was identified between lesion type and anatomical location. Conclusions: Conjunctival and eyelid lesions in this population were predominantly benign and associated with demographic and environmental factors. These findings highlight the importance of structured screening strategies and early diagnosis to improve clinical outcomes and support public health policies aimed at reducing the burden of ocular disease within the SUS.
- 16 June 2026
- Published by MDPI AG in Journal of Clinical & Translational Ophthalmology
- Vol. 4 (2) , 16
Open AccessClinical Profile of Conjunctival and Eyelid Lesions in Patients Referred to the Ophthalmology Service of the Brazilian Public Health System (SUS)
Introduction: Conjunctival and eyelid lesions encompass a broad spectrum of conditions, ranging from benign entities to malignant neoplasms, and may significantly impact ocular health and quality of life. Their occurrence is influenced by environmental exposure, demographic characteristics, and access to healthcare services. In public health settings, delayed diagnosis and limited access to specialized care may contribute to disease progression. Objective: To characterize the clinical and epidemiological profile of conjunctival and eyelid lesions in patients treated at a referral ophthalmology service within the Brazilian Unified Health System (SUS). Methods: This retrospective observational study reviewed medical records of patients diagnosed with conjunctival and/or eyelid lesions during ophthalmologic screening campaigns. Clinical and demographic variables were analyzed using descriptive statistics to assess prevalence and distribution patterns. Results: A total of 66 patients were included. Conjunctival involvement predominated (78.8%), with the nasal region being the most frequently affected location (62.1%). Pterygium was the most prevalent diagnosis (31.8%), followed by racial melanosis (15.2%) and melanocytic nevus (12.1%). No statistically significant differences were observed according to sex or lesion laterality. However, a significant association was identified between lesion type and anatomical location. Conclusions: Conjunctival and eyelid lesions in this population were predominantly benign and associated with demographic and environmental factors. These findings highlight the importance of structured screening strategies and early diagnosis to improve clinical outcomes and support public health policies aimed at reducing the burden of ocular disease within the SUS.
- Open Access
- 1 April 2026
- Published by MDPI AG in Future Pharmacology
- Vol. 6 (2) , 22
Hereditary Hemochromatosis: Pathophysiological Basis and Emerging Therapeutic Approaches—A Systematic Review of Clinical Evidence
Introduction: Hereditary hemochromatosis is a genetic disorder characterized by dysregulation of iron homeostasis, resulting in excessive intestinal iron absorption and progressive iron deposition in vital organs. The hepcidin–ferroportin axis plays a central role in the pathophysiology of the disease, particularly in cases associated with mutations in the HFE gene. Persistent iron overload may lead to progressive injury in target organs and functional impairment. Methods: A brief description of the pathological basis of hereditary hemochromatosis was conducted together with a systematic review of interventional clinical trials registered on ClinicalTrials.gov. Studies with available results were included regardless of clinical phase or recruitment status. Relevant data regarding therapeutic interventions and iron metabolism parameters were extracted and descriptively analyzed. Results: Three studies met the inclusion criteria: one evaluating the hepcidin mimetic Rusfertide (PTG-300), another assessing synthetic hepcidin LJPC-401, and a third investigating the iron chelator Deferasirox. Discussion: These therapies demonstrated biological activity in modulating iron metabolism parameters; however, none proved superior to therapeutic phlebotomy, which remains the standard treatment, in terms of efficacy. Conclusions: Although emerging pharmacological therapies targeting iron metabolism show promising biological effects, current clinical evidence remains limited. Therapeutic phlebotomy continues to represent the first-line treatment for hereditary hemochromatosis, and further clinical trials are necessary to determine the potential role of these novel therapeutic approaches.
- 1 April 2026
- Published by MDPI AG in Future Pharmacology
- Vol. 6 (2) , 22
Open AccessHereditary Hemochromatosis: Pathophysiological Basis and Emerging Therapeutic Approaches—A Systematic Review of Clinical Evidence
Introduction: Hereditary hemochromatosis is a genetic disorder characterized by dysregulation of iron homeostasis, resulting in excessive intestinal iron absorption and progressive iron deposition in vital organs. The hepcidin–ferroportin axis plays a central role in the pathophysiology of the disease, particularly in cases associated with mutations in the HFE gene. Persistent iron overload may lead to progressive injury in target organs and functional impairment. Methods: A brief description of the pathological basis of hereditary hemochromatosis was conducted together with a systematic review of interventional clinical trials registered on ClinicalTrials.gov. Studies with available results were included regardless of clinical phase or recruitment status. Relevant data regarding therapeutic interventions and iron metabolism parameters were extracted and descriptively analyzed. Results: Three studies met the inclusion criteria: one evaluating the hepcidin mimetic Rusfertide (PTG-300), another assessing synthetic hepcidin LJPC-401, and a third investigating the iron chelator Deferasirox. Discussion: These therapies demonstrated biological activity in modulating iron metabolism parameters; however, none proved superior to therapeutic phlebotomy, which remains the standard treatment, in terms of efficacy. Conclusions: Although emerging pharmacological therapies targeting iron metabolism show promising biological effects, current clinical evidence remains limited. Therapeutic phlebotomy continues to represent the first-line treatment for hereditary hemochromatosis, and further clinical trials are necessary to determine the potential role of these novel therapeutic approaches.
- Open Access
- 2 January 2026
- Published by Instituto para o Desenvolvimento da Educacao in Journal of Health & Biological Sciences
- Vol. 14 (1)
Cardiac ablation compared to drug therapy in the treatment of atrial fibrillation
Objective: to evaluate differences in atrial fibrillation recurrence rates between patients undergoing catheter ablation and those receiving drug therapy.Methods: systematic searches were conducted in PubMed and SciELO databases for clinical studies published between 2020-2024 evaluating symptomatic atrial fibrillation outcomes. The PICO strategy was implemented using MeSH descriptors with Boolean operators. Inclusion criteria comprised comparative studies between drug intervention and catheter ablation with recurrence as primary endpoint. Results: seven clinical studies were analyzed: three comparing radiofrequency ablation and four comparing cryoablation with class I and III antiarrhythmic agents. All studies demonstrated lower atrial fibrillation recurrence rates with ablation compared to pharmacological treatment. Catheter ablation showed superior efficacy in reducing atrial tachyarrhythmia recurrence, with success rates of 48-75% versus 30-45% for drug therapy. Cryoablation as initial therapy proved superior to antiarrhythmics in preventingparoxysmal atrial fibrillation recurrence. Ablation demonstrated superior efficacy regardless of atrial fibrillation type, showing better symptomatic controland quality of life across paroxysmal, persistent, and long-standing persistent categories. Patients undergoing ablation reported improved functional capacity and reduced symptom burden compared to pharmacological management alone. Conclusion: catheter ablation demonstrates superior efficiency in reducing symptoms and atrial fibrillation recurrence compared to pharmacological therapy, establishing it as the preferred therapeutic approach for appropriate candidates.
- 2 January 2026
- Published by Instituto para o Desenvolvimento da Educacao in Journal of Health & Biological Sciences
- Vol. 14 (1)
Open AccessCardiac ablation compared to drug therapy in the treatment of atrial fibrillation
Objective: to evaluate differences in atrial fibrillation recurrence rates between patients undergoing catheter ablation and those receiving drug therapy.Methods: systematic searches were conducted in PubMed and SciELO databases for clinical studies published between 2020-2024 evaluating symptomatic atrial fibrillation outcomes. The PICO strategy was implemented using MeSH descriptors with Boolean operators. Inclusion criteria comprised comparative studies between drug intervention and catheter ablation with recurrence as primary endpoint. Results: seven clinical studies were analyzed: three comparing radiofrequency ablation and four comparing cryoablation with class I and III antiarrhythmic agents. All studies demonstrated lower atrial fibrillation recurrence rates with ablation compared to pharmacological treatment. Catheter ablation showed superior efficacy in reducing atrial tachyarrhythmia recurrence, with success rates of 48-75% versus 30-45% for drug therapy. Cryoablation as initial therapy proved superior to antiarrhythmics in preventingparoxysmal atrial fibrillation recurrence. Ablation demonstrated superior efficacy regardless of atrial fibrillation type, showing better symptomatic controland quality of life across paroxysmal, persistent, and long-standing persistent categories. Patients undergoing ablation reported improved functional capacity and reduced symptom burden compared to pharmacological management alone. Conclusion: catheter ablation demonstrates superior efficiency in reducing symptoms and atrial fibrillation recurrence compared to pharmacological therapy, establishing it as the preferred therapeutic approach for appropriate candidates.
- Open Access
- 10 October 2025
- Published by Spandidos Publications in Biomedical Reports
- Vol. 23 (6) , 1-10
Expression of ACE2 and TMPRSS2 and the severity of COVID‑19
Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2), the virus responsible for coronavirus disease 2019 (COVID‑19), uses the angiotensin‑converting enzyme 2 (ACE2) receptor and transmembrane serine protease 2 (TMPRSS2) to enter host cells. Variability in gene expression of these entry factors has been hypothesized to influence susceptibility and disease severity. The present study aimed to evaluate the expression of ACE2 and TMPRSS2 in nasopharyngeal cells and their association with COVID‑19 infection and clinical outcomes. Nasopharyngeal samples from 491 individuals (aged 18‑80 years) treated in public hospitals in Brazil during 2020 were analyzed. Patients were categorized based on SARS‑CoV‑2 reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) results and disease severity (including intensive care unit admission). Gene expression levels of ACE2 and TMPRSS2 were quantified using RT‑qPCR, and statistical analyses assessed associations with infection status, age, sex, and disease severity. The findings revealed that infected individuals were significantly older (P=0.0010) and predominantly male (52.9%). ACE2 expression was significantly reduced in SARS‑CoV‑2‑positive individuals compared with negative individuals (PACE2 levels were found in moderately symptomatic SARS‑CoV‑2‑negative individuals. TMPRSS2 expression did not significantly differ by infection status or disease severity. In summary, ACE2 downregulation appeared to be associated with SARS‑CoV‑2 infection, potentially reflecting viral evasion mechanisms. However, neither ACE2 nor TMPRSS2 gene expression in the nasopharynx served as a reliable biomarker for predicting COVID‑19 severity. These findings underscore the need for multifactorial models integrating host, viral, and clinical factors to improve our understanding disease progression.
- 10 October 2025
- Published by Spandidos Publications in Biomedical Reports
- Vol. 23 (6) , 1-10
Open AccessExpression of ACE2 and TMPRSS2 and the severity of COVID‑19
Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2), the virus responsible for coronavirus disease 2019 (COVID‑19), uses the angiotensin‑converting enzyme 2 (ACE2) receptor and transmembrane serine protease 2 (TMPRSS2) to enter host cells. Variability in gene expression of these entry factors has been hypothesized to influence susceptibility and disease severity. The present study aimed to evaluate the expression of ACE2 and TMPRSS2 in nasopharyngeal cells and their association with COVID‑19 infection and clinical outcomes. Nasopharyngeal samples from 491 individuals (aged 18‑80 years) treated in public hospitals in Brazil during 2020 were analyzed. Patients were categorized based on SARS‑CoV‑2 reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) results and disease severity (including intensive care unit admission). Gene expression levels of ACE2 and TMPRSS2 were quantified using RT‑qPCR, and statistical analyses assessed associations with infection status, age, sex, and disease severity. The findings revealed that infected individuals were significantly older (P=0.0010) and predominantly male (52.9%). ACE2 expression was significantly reduced in SARS‑CoV‑2‑positive individuals compared with negative individuals (PACE2 levels were found in moderately symptomatic SARS‑CoV‑2‑negative individuals. TMPRSS2 expression did not significantly differ by infection status or disease severity. In summary, ACE2 downregulation appeared to be associated with SARS‑CoV‑2 infection, potentially reflecting viral evasion mechanisms. However, neither ACE2 nor TMPRSS2 gene expression in the nasopharynx served as a reliable biomarker for predicting COVID‑19 severity. These findings underscore the need for multifactorial models integrating host, viral, and clinical factors to improve our understanding disease progression.
- Open Access
- 29 August 2025
- Published by MDPI AG in Physiologia
- Vol. 5 (3) , 28
Tears and Saliva as Biological Matrices for Vitamin D and Glucose Assessment: A Pilot Study
Background: Several studies have established correlations between low serum levels of vitamin D and various pathologies, such as diabetes mellitus and its complications. However, few studies analyze its levels in matrices other than blood plasma, such as tears and saliva. In this study, we aimed to demonstrate the feasibility of using tears and saliva as alternative biological matrices for laboratory assessment of vitamin D and glucose concentration in individuals with type II diabetes mellitus and healthy individuals, using the electrochemiluminescence method. Methods: This study included volunteers with type II diabetes and healthy controls, excluding those with certain comorbidities or a BMI ≥ 40. Blood, tear, and saliva samples were taken after 3 h of fasting for biochemical analysis of fasting glucose and vitamin D. Statistical analysis was conducted using GraphPad Prism® 8.0—with Pearson and other tests to evaluate correlations—at a significance level of 5% and test power > 95%. Results: A negative correlation between serum vitamin D values and those found in saliva (p = 0.041) was found, as well as a positive correlation between serum glucose values and those found in tears (p = 0.0254). Conclusions: Tears and saliva samples can be used as proxies for venous blood samples in specific situations, such as studying blood glucose levels and vitamin D levels. However, expanding the sample size is essential to confirm the correlation and develop an accurate equation for estimating serum levels of these markers using these alternative matrices.
- 29 August 2025
- Published by MDPI AG in Physiologia
- Vol. 5 (3) , 28
Open AccessTears and Saliva as Biological Matrices for Vitamin D and Glucose Assessment: A Pilot Study
Background: Several studies have established correlations between low serum levels of vitamin D and various pathologies, such as diabetes mellitus and its complications. However, few studies analyze its levels in matrices other than blood plasma, such as tears and saliva. In this study, we aimed to demonstrate the feasibility of using tears and saliva as alternative biological matrices for laboratory assessment of vitamin D and glucose concentration in individuals with type II diabetes mellitus and healthy individuals, using the electrochemiluminescence method. Methods: This study included volunteers with type II diabetes and healthy controls, excluding those with certain comorbidities or a BMI ≥ 40. Blood, tear, and saliva samples were taken after 3 h of fasting for biochemical analysis of fasting glucose and vitamin D. Statistical analysis was conducted using GraphPad Prism® 8.0—with Pearson and other tests to evaluate correlations—at a significance level of 5% and test power > 95%. Results: A negative correlation between serum vitamin D values and those found in saliva (p = 0.041) was found, as well as a positive correlation between serum glucose values and those found in tears (p = 0.0254). Conclusions: Tears and saliva samples can be used as proxies for venous blood samples in specific situations, such as studying blood glucose levels and vitamin D levels. However, expanding the sample size is essential to confirm the correlation and develop an accurate equation for estimating serum levels of these markers using these alternative matrices.
- Open Access
- 1 November 2024
- Published by Taylor & Francis in International Medical Case Reports Journal
- Vol. ume 17, 891-894
Atypical Presentation of Choroidal Osteoma: Two Case Reports
Choroidal osteoma is a rare, benign, osseous choristoma presenting as an orange-yellow, well-defined fundus mass. It presents unilaterally in most cases, has a predilection for the female sex, and favor a juxtapapillary location, becoming clinically manifest when it involves the macula. Almost 60% of eyes with osteoma may suffer significant visual loss. Choroidal osteomas can easily be mistaken for other conditions with similar presentations. We herein report two rare cases presentation of choroidal osteoma: a 74-year-old male with 2-year blurred vision in the right eye (RE) initially misdiagnosed with age-related macular degeneration received intravitreal injections and after a multimodal evaluation, following cataract surgery in RE, confirmed to be choroidal osteoma and a 19-year-old female with a history of choroidal hemangioma presented with blurred vision in her left eye (LE), with examination revealed an irregular orange-yellow lesion along the superotemporal arcade with serous macular detachment, later diagnosed as choroidal osteoma.
- 1 November 2024
- Published by Taylor & Francis in International Medical Case Reports Journal
- Vol. ume 17, 891-894
Open AccessAtypical Presentation of Choroidal Osteoma: Two Case Reports
Choroidal osteoma is a rare, benign, osseous choristoma presenting as an orange-yellow, well-defined fundus mass. It presents unilaterally in most cases, has a predilection for the female sex, and favor a juxtapapillary location, becoming clinically manifest when it involves the macula. Almost 60% of eyes with osteoma may suffer significant visual loss. Choroidal osteomas can easily be mistaken for other conditions with similar presentations. We herein report two rare cases presentation of choroidal osteoma: a 74-year-old male with 2-year blurred vision in the right eye (RE) initially misdiagnosed with age-related macular degeneration received intravitreal injections and after a multimodal evaluation, following cataract surgery in RE, confirmed to be choroidal osteoma and a 19-year-old female with a history of choroidal hemangioma presented with blurred vision in her left eye (LE), with examination revealed an irregular orange-yellow lesion along the superotemporal arcade with serous macular detachment, later diagnosed as choroidal osteoma.
- Open Access
- 14 September 2023
- Published by Revista de Epidemiologia e Saúde Pública in Revista de Epidemiologia e Saúde Pública - RESP
- Vol. 1 (3)
VARIAÇÕES TOPOGRÁFICAS EM PACIENTES SUBMETIDOS A CIRURGIA DE ESTRABISMO
Introdução: A correção do estrabismo por meio de cirurgia ocular é uma forma amplamente utilizada de melhorar a visão binocular e a qualidade de vida dos pacientes afetados. No entanto, variações topográficas e alterações refracionais após essas cirurgias são descritas na literatura. A interação entre as modificações cirúrgicas na inserção dos músculos extraoculares e as variações na topografia da córnea ainda é pouco explorada. Objetivo: Avaliar a correlação entre as alterações cirúrgicas das inserções dos músculos extraoculares e as variações na topografia da córnea de pacientes submetidos a cirurgia para correção de estrabismo pela equipe do setor de estrabismo da Faculdade de Medicina do ABC. Métodos: O estudo comparou a topografia de córnea pré-operatória e após 2 meses de cirurgia de estrabismo, utilizando a tomografia de córnea (Orbscan R). Foram avaliadas as diferenças nos valores de astigmatismo e do seu eixo. Resultados: O valor do astigmatismo não apresentou variação significativa. Houve variação do eixo do astigmatismo clinicamente significativa com média de 17,87 +/ - 24,58. Conclusão: Apesar de não se notar variação significativa do valor do astigmatismo nos olhos analisados, variações no seu eixo foram observadas após a correção cirúrgica do estrabismo.
- 14 September 2023
- Published by Revista de Epidemiologia e Saúde Pública in Revista de Epidemiologia e Saúde Pública - RESP
- Vol. 1 (3)
Open AccessVARIAÇÕES TOPOGRÁFICAS EM PACIENTES SUBMETIDOS A CIRURGIA DE ESTRABISMO
Introdução: A correção do estrabismo por meio de cirurgia ocular é uma forma amplamente utilizada de melhorar a visão binocular e a qualidade de vida dos pacientes afetados. No entanto, variações topográficas e alterações refracionais após essas cirurgias são descritas na literatura. A interação entre as modificações cirúrgicas na inserção dos músculos extraoculares e as variações na topografia da córnea ainda é pouco explorada. Objetivo: Avaliar a correlação entre as alterações cirúrgicas das inserções dos músculos extraoculares e as variações na topografia da córnea de pacientes submetidos a cirurgia para correção de estrabismo pela equipe do setor de estrabismo da Faculdade de Medicina do ABC. Métodos: O estudo comparou a topografia de córnea pré-operatória e após 2 meses de cirurgia de estrabismo, utilizando a tomografia de córnea (Orbscan R). Foram avaliadas as diferenças nos valores de astigmatismo e do seu eixo. Resultados: O valor do astigmatismo não apresentou variação significativa. Houve variação do eixo do astigmatismo clinicamente significativa com média de 17,87 +/ - 24,58. Conclusão: Apesar de não se notar variação significativa do valor do astigmatismo nos olhos analisados, variações no seu eixo foram observadas após a correção cirúrgica do estrabismo.
- Open Access
- 14 September 2023
- Published by Revista de Epidemiologia e Saúde Pública in Revista de Epidemiologia e Saúde Pública - RESP
- Vol. 1 (3)
TRATAMENTO DE TUBERCULOSE PULMONAR EM BACILOS MULTIRRESISTENTES: REVISÃO DA LITERATURA
Introdução: A tuberculose é um problema significativo de saúde pública em todo o mundo, e o Brasil tem priorizado seu controle e manejo conforme orientado pelo Ministério da Saúde. Essa doença infecciosa é causada pela Mycobacterium tuberculosis, comumente conhecida como bacilo de Koch. Embora a tuberculose possa afetar múltiplos órgãos ou sistemas, a forma pulmonar é particularmente relevante devido à sua transmissão de pessoa para pessoa por meio da inalação de aerossóis contendo o bacilo. Objetivo: Explorar os aspectos do tratamento da tuberculose multirresistente, destacando o papel crucial dos farmacêuticos na identificação, intervenção e prevenção da doença. A tuberculose multirresistente ocorre quando a Mycobacterium tuberculosis desenvolve mecanismos de resistência aos medicamentos de primeira linha utilizados no tratamento padrão da tuberculose, tornando os medicamentos ineficazes. A resistência pode ser classificada como natural, primária ou adquirida, dependendo dos fatores subjacentes. Além disso, a resistência é classificada com base no número de medicamentos de primeira linha aos quais o bacilo de Koch desenvolveu resistência, resultando em classificações como monorresistência, polirresistência, TB-MDR e TB-XDR. É fundamental priorizar a prevenção da tuberculose tornar-se incurável, abordando o surgimento de cepas resistentes aos medicamentos.
- 14 September 2023
- Published by Revista de Epidemiologia e Saúde Pública in Revista de Epidemiologia e Saúde Pública - RESP
- Vol. 1 (3)
Open AccessTRATAMENTO DE TUBERCULOSE PULMONAR EM BACILOS MULTIRRESISTENTES: REVISÃO DA LITERATURA
Introdução: A tuberculose é um problema significativo de saúde pública em todo o mundo, e o Brasil tem priorizado seu controle e manejo conforme orientado pelo Ministério da Saúde. Essa doença infecciosa é causada pela Mycobacterium tuberculosis, comumente conhecida como bacilo de Koch. Embora a tuberculose possa afetar múltiplos órgãos ou sistemas, a forma pulmonar é particularmente relevante devido à sua transmissão de pessoa para pessoa por meio da inalação de aerossóis contendo o bacilo. Objetivo: Explorar os aspectos do tratamento da tuberculose multirresistente, destacando o papel crucial dos farmacêuticos na identificação, intervenção e prevenção da doença. A tuberculose multirresistente ocorre quando a Mycobacterium tuberculosis desenvolve mecanismos de resistência aos medicamentos de primeira linha utilizados no tratamento padrão da tuberculose, tornando os medicamentos ineficazes. A resistência pode ser classificada como natural, primária ou adquirida, dependendo dos fatores subjacentes. Além disso, a resistência é classificada com base no número de medicamentos de primeira linha aos quais o bacilo de Koch desenvolveu resistência, resultando em classificações como monorresistência, polirresistência, TB-MDR e TB-XDR. É fundamental priorizar a prevenção da tuberculose tornar-se incurável, abordando o surgimento de cepas resistentes aos medicamentos.
- Open Access
- 1 July 2023
- Published by Walter de Gruyter GmbH in Revista Romana de Medicina de Laborator
- Vol. 31 (3) , 197-204
Platelet index alterations in acute ST-elevation myocardial infarct: A retrospective pilot study
Introduction: Cardiovascular diseases (CVD) are responsible for approximately 17.9 millions of deaths every year, with a higher impact on low and middle-income populations. Despite traditional risk factors, asymptomatic individuals with atherosclerosis have been identified, and new biomarkers are being sought to better predict CVD risk. This study aims to investigate the relationship between platelets indices and biochemical variability in the first day after patient admission in the hospital. Methods: A pilot study was conducted to analyze 73 medical records of patients who experienced acute myocardial infarction, to analyze the association among mean platelet volume (MPV), platelet count (PC), creatine phosphokinase (CPK), creatine phosphokinase-MB (CKMB) and ultra-sensitive cardiac troponin I (TnI-us) between the first and second sampling (1-hour intervals), to investigate acute ST-segment elevation myocardial infarction. Results and conclusion: The biochemical analysis showed no significant difference in CPK CK MB, TnI-us, MPV and PC levels between the first and second samples. A negative correlation between PC and MPV and a moderate negative correlation between PC and CPK were found in our AMI patients within 24 hours of hospital admission.
- 1 July 2023
- Published by Walter de Gruyter GmbH in Revista Romana de Medicina de Laborator
- Vol. 31 (3) , 197-204
Open AccessPlatelet index alterations in acute ST-elevation myocardial infarct: A retrospective pilot study
Introduction: Cardiovascular diseases (CVD) are responsible for approximately 17.9 millions of deaths every year, with a higher impact on low and middle-income populations. Despite traditional risk factors, asymptomatic individuals with atherosclerosis have been identified, and new biomarkers are being sought to better predict CVD risk. This study aims to investigate the relationship between platelets indices and biochemical variability in the first day after patient admission in the hospital. Methods: A pilot study was conducted to analyze 73 medical records of patients who experienced acute myocardial infarction, to analyze the association among mean platelet volume (MPV), platelet count (PC), creatine phosphokinase (CPK), creatine phosphokinase-MB (CKMB) and ultra-sensitive cardiac troponin I (TnI-us) between the first and second sampling (1-hour intervals), to investigate acute ST-segment elevation myocardial infarction. Results and conclusion: The biochemical analysis showed no significant difference in CPK CK MB, TnI-us, MPV and PC levels between the first and second samples. A negative correlation between PC and MPV and a moderate negative correlation between PC and CPK were found in our AMI patients within 24 hours of hospital admission.